PPAR panagonists have also been confirmed to significantly reduce abnormally elevated blood glucose levels without causing hypoglycaemia, improve insulin resistance, and moderate impairment of insulin secretion (19, 20). The gene discussed is INS; the disease is Hypoglycemia.